Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Chatel

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Plos One|October 3, 2012
Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivoDaniela Pontes, Silvia Innocentin, Silvina Del Carmen, et al.
BMC Biotechnology|August 10, 2014
Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitisMeritxell Zurita-Turk, Silvina Del Carmen, Ana C G Santos, et al.
JCI Insight|May 10, 2022
Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammationSothea Touch, Emmanuelle Godefroy, Nathalie Rolhion, et al.
Gut Microbes|June 18, 2025
The Microbial Anti-Inflammatory Molecule (MAM) is a key protein processed and exported to <i>Faecalibacterium duncaniae</i> envelopeThaís Vilela Rodrigues, Sylvain Marthey, Sandrine Auger, et al.
Frontiers in Immunology|June 12, 2023
<i>Staphylococcus epidermidis</i> isolates from atopic or healthy skin have opposite effect on skin cells: potential implication of the AHR pathway modulationLeslie Landemaine, Gregory Da Costa, Elsa Fissier, et al.
United European Gastroenterology Journal|April 19, 2025
Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease PatientsPaul Mclellan, Sandrine Auger, Marie Therese Goudiaby, et al.
Frontiers in Immunology|April 9, 2024
<i>Faecalibacterium duncaniae</i> as a novel next generation probiotic against influenzaLoïc Chollet, Séverine Heumel, Lucie Deruyter, et al.
Environmental Microbiology|July 21, 2019
Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiotaNatalia M Breyner, Priscilla Bagano Vilas Boas, Gabriel Fernandes, et al.
Gut Microbes|January 29, 2022
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptomsMaëva Meynier, Elodie Baudu, Nathalie Rolhion, et al.
Microbial Cell Factories|February 15, 2017
Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositisRodrigo D Carvalho, Natalia Breyner, Zelia Menezes-Garcia, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Plos One|October 3, 2012
Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivoDaniela Pontes, Silvia Innocentin, Silvina Del Carmen, et al.
BMC Biotechnology|August 10, 2014
Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitisMeritxell Zurita-Turk, Silvina Del Carmen, Ana C G Santos, et al.
JCI Insight|May 10, 2022
Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammationSothea Touch, Emmanuelle Godefroy, Nathalie Rolhion, et al.
Gut Microbes|June 18, 2025
The Microbial Anti-Inflammatory Molecule (MAM) is a key protein processed and exported to <i>Faecalibacterium duncaniae</i> envelopeThaís Vilela Rodrigues, Sylvain Marthey, Sandrine Auger, et al.
Frontiers in Immunology|June 12, 2023
<i>Staphylococcus epidermidis</i> isolates from atopic or healthy skin have opposite effect on skin cells: potential implication of the AHR pathway modulationLeslie Landemaine, Gregory Da Costa, Elsa Fissier, et al.
United European Gastroenterology Journal|April 19, 2025
Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease PatientsPaul Mclellan, Sandrine Auger, Marie Therese Goudiaby, et al.
Frontiers in Immunology|April 9, 2024
<i>Faecalibacterium duncaniae</i> as a novel next generation probiotic against influenzaLoïc Chollet, Séverine Heumel, Lucie Deruyter, et al.
Environmental Microbiology|July 21, 2019
Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiotaNatalia M Breyner, Priscilla Bagano Vilas Boas, Gabriel Fernandes, et al.
Gut Microbes|January 29, 2022
AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptomsMaëva Meynier, Elodie Baudu, Nathalie Rolhion, et al.
Microbial Cell Factories|February 15, 2017
Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositisRodrigo D Carvalho, Natalia Breyner, Zelia Menezes-Garcia, et al.
Pageof 7